Yahoo
Shenzhen - Delayed Quote CNY

Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ)

21.78 -0.14 (-0.64%)
At close: October 30 at 3:04:01 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
433,309.60
541,449.76
648,974.12
602,284.31
688,625.99
Cost of Revenue
282,988.33
310,569.16
370,915.57
345,055.05
354,881.87
Gross Profit
150,321.27
230,880.59
278,058.56
257,229.25
333,744.12
Operating Expense
308,724.32
352,648.04
345,994.37
363,569.37
338,428.68
Operating Income
-158,403.05
-121,767.44
-67,935.82
-106,340.12
-4,684.57
Net Non Operating Interest Income Expense
4,316.61
4,722.40
5,133.80
7,141.08
11,246.97
Pretax Income
-202,029.13
-238,763.51
-80,140.59
-151,986.08
-7,823.95
Tax Provision
-6,304.63
-3,333.31
-6,370.73
-23,742.67
74.18
Net Income Common Stockholders
-192,441.18
-231,265.72
-69,348.66
-120,822.82
-14,029.61
Basic EPS
-1.47
-1.77
-0.53
-0.93
-0.11
Diluted EPS
-1.47
-1.77
-0.53
-0.93
-0.11
Basic Average Shares
130,965.18
130,658.60
130,846.53
129,917.01
127,541.94
Diluted Average Shares
130,965.18
130,658.60
130,846.53
129,917.01
127,541.94
Total Operating Income as Reported
-196,193.08
-234,104.33
-75,710.06
-143,073.03
-6,822.52
Rent Expense Supplemental
658.96
672.76
768.15
662.29
689.71
Total Expenses
591,712.65
663,217.20
716,909.94
708,624.43
693,310.56
Net Income from Continuing & Discontinued Operation
-192,441.18
-231,265.72
-69,348.66
-120,822.82
-14,029.61
Normalized Income
-146,225.32
-95,485.32
-42,095.45
-70,567.17
4,290.11
Interest Income
5,643.91
6,412.95
8,139.51
9,991.68
12,857.61
Interest Expense
1,033.80
1,390.34
2,296.47
2,390.17
1,117.25
Net Interest Income
4,316.61
4,722.40
5,133.80
7,141.08
11,246.97
EBIT
-200,995.33
-237,373.17
-77,844.12
-149,595.90
-6,706.70
EBITDA
-200,995.33
-140,026.95
14,437.22
-78,525.02
46,766.38
Reconciled Cost of Revenue
282,988.33
310,569.16
370,915.57
345,055.05
354,881.87
Reconciled Depreciation
92,797.70
97,346.22
92,281.34
71,070.89
53,473.08
Net Income from Continuing Operation Net Minority Interest
-192,441.18
-231,265.72
-69,348.66
-120,822.82
-14,029.61
Total Unusual Items Excluding Goodwill
-47,704.56
-137,702.83
-29,606.78
-59,559.86
-24,426.29
Total Unusual Items
-47,704.56
-137,702.83
-29,606.78
-59,559.86
-24,426.29
Normalized EBITDA
-153,290.77
-2,324.12
44,044.01
-18,965.15
71,192.67
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,488.70
-1,922.43
-2,353.57
-9,304.21
-6,106.57
12/31/2022 - 8/8/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: